育龄女性化疗相关卵巢储备功能减退的预测模型
本研究为前瞻性队列研究,纳入青春期后新诊断需化疗的年轻女性癌症患者,构建并内部验证预测化疗后卵巢储备功能减退(DOR)的临床工具。多变量逻辑回归模型纳入年龄、癌症类型、烷化剂暴露和基线AMH值,预测化疗后DOR的ROC曲线下面积为0.89。
要点
- 预测模型包含年龄、癌症类型、烷化剂暴露和基线AMH四项指标。
- 模型预测化疗后DOR的AUC为0.89,具有较好区分度。
- DOR定义为化疗结束后8-24个月血清AMH<1 ng/mL。
核心结论
- 基于年龄、癌症类型、烷化剂使用和基线AMH的预测工具可识别化疗后DOR高危女性。
研究设计与样本
- 前瞻性队列研究,纳入青春期后新诊断需化疗的年轻女性癌症患者,在大学医院开展。
主要发现
- 多变量逻辑回归模型预测化疗后DOR的AUC为0.89。
关键数值与推荐
- DOR定义为化疗完成并恢复后8-24个月血清AMH<1 ng/mL。
- 预测模型纳入年龄、癌症类型、烷化剂暴露和基线AMH值。
临床怎么用
- 治疗前可利用年龄、癌症类型、烷化剂计划和基线AMH评估化疗后DOR风险。
局限性
- 研究仅进行了内部验证,未报告外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and internally validate a clinical predictive tool to assess the likelihood that a young cancer patient will experience diminished ovarian reserve (DOR) after chemotherapy. DESIGN: Prospective cohort study. SETTING: University hospitals. PATIENT(S): Postpubertal adolescent and young adult women with a new diagnosis of cancer requiring chemotherapy. INTERVENTION: None. MAIN OUTCOME MEASURE(S): Diminished ovarian reserve after completion of and recovery from chemotherapy, defined as serum antimüllerian hormone (AMH) <1 ng/mL at 8-24 months after completion of chemotherapy. RESULT(S): A multivariable logistic regression model which includes age, cancer type, exposure to an alkylating agent, and baseline AMH value accurately predicts the diagnosis of DOR after chemotherapy with an area under the receiver operating characteristic curve of 0.89. CONCLUSION(S): Pretreatment information on age, cancer type, use of an alkylating agent, and baseline AMH levels make up a clinically useful predictive tool to identify which women are most at risk for DOR caused by chemotherapy.
引用
- Hopeman MM, Cameron KE, Prewitt M, et al. A predictive model for chemotherapy-related diminished ovarian reserve in reproductive-age women. Fertil Steril. 2021. PMID: 33455812. doi:10.1016/j.fertnstert.2020.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。